US 7790728
Pyrazine derivatives useful as adenosine receptor antagonists
granted A61PA61P1/00A61P1/04
Quick answer
US patent 7790728 (Pyrazine derivatives useful as adenosine receptor antagonists) held by Laboratories Almirall, S.A. expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Laboratories Almirall, S.A.
- Grant date
- Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/06